Pinnacle Wealth Management Advisory Group’s CorMedix CRMD Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,000	Closed	-$43.3K	–	364
2024 Q2	$43.3K	Hold	10,000	–	–	﹤0.01%	347
2024 Q1	$42.4K	Hold	10,000	–	–	﹤0.01%	345
2023 Q4	$37.6K	Hold	10,000	–	–	﹤0.01%	331
2023 Q3	$37K	Hold	10,000	–	–	﹤0.01%	310
2023 Q2	$39.6K	Hold	10,000	–	–	﹤0.01%	324
2023 Q1	$41.4K	Hold	10,000	–	–	0.01%	312
2022 Q4	$42.2K	Hold	10,000	–	–	0.01%	293
2022 Q3	$28K	Buy	+10,000	New	+$41.6K	﹤0.01%	273

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's CRMD Position: Q3 2024 in Review

Pinnacle Wealth Management Advisory Group sold out of CorMedix (CRMD) in Q3 2024, closing a stake of 10,000 shares — an estimated $43.3K sold.

Pinnacle Wealth Management Advisory Group first reported a position in CRMD in Q3 2022 and held it in 8 quarters. The position peaked at $43.3K in Q2 2024. 102 funds tracked by Wall St. Rank hold CRMD as of Q3 2024.

Pinnacle Wealth Management Advisory Group reported no remaining CorMedix position as of Q3 2024 after selling out during the quarter.
Pinnacle Wealth Management Advisory Group sold 10,000 CorMedix shares in Q3 2024, an estimated $43.3K.
Pinnacle Wealth Management Advisory Group first reported a position in CorMedix in Q3 2022 and held it in 8 quarters.
Pinnacle Wealth Management Advisory Group's CorMedix position peaked at $43.3K in Q2 2024.
102 funds tracked by Wall St. Rank held CorMedix as of Q3 2024.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q3 2024, filed 16 Oct 2024.